Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
23 hedge funds and large institutions have $5.45M invested in Celgene Corporation Contingent Value Rights in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
25% more capital invested
Capital invested by funds: $4.35M → $5.45M (+$1.1M)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
0% more funds holding
Funds holding: 23 → 23 (0)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FA
FCG Advisors
Chatham,
New Jersey
|
+$1.08M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$60.5K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$33.7K |
| 4 |
Morgan Stanley
New York
|
+$29.9K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$10.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$287K |
| 2 |
CC
Cannell & Co
New York
|
-$85K |
| 3 |
Millennium Management
New York
|
-$62.8K |
| 4 |
PC
Pomelo Capital
New York
|
-$51K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$6K |
CELGZ Hedge Fund Activity: Q4 2014 in Review
23 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q4 2014, worth a combined $5.45M — up 25% from $4.35M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CELGZ positions and 4 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.
The largest buyer was FCG Advisors, opening a new position worth an estimated $1.08M. The largest seller was Opaleye Management, cutting an estimated $287K.
- 23 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $5.45M of Celgene Corporation Contingent Value Rights stock for Q4 2014, up 25% quarter-over-quarter.
- 5 funds opened new Celgene Corporation Contingent Value Rights positions in Q4 2014 and 4 closed out, a net change of +1 holder.
- The largest Celgene Corporation Contingent Value Rights buyer in Q4 2014 was FCG Advisors, an estimated $1.08M added.
- The largest Celgene Corporation Contingent Value Rights seller in Q4 2014 was Opaleye Management, an estimated $287K sold.
Based on aggregated 13F filings for Q4 2014.